US Manufacturing Index Rises To 43, Highest Since 2020
Piper Sandler Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $160
Neurocrine Biosciences Positioned for Growth Amid AbbVie's Setback in Muscarinic Program
Neurocrine Biosciences To Present At UBS Global Healthcare Conference; Webcast At 4:15 PM ET
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
AbbVie's Disappointing Schizophrenia Drug Trial Bodes Well for Rival Bristol Myers, Analysts Say